APA (7th ed.) Citation

Eva eRettinger, Andreas eGlatthaar, Behnaz eAhangarian Abhari, Sarah eOelsner, Verena ePfirrmann, Sabine eHuenecke, . . . Peter eBader. (2014). SMAC mimetic BV6 enables sensitization of resistant tumor cells but also affects cytokine-induced killer (CIK) cells: A potential challenge for combination therapy. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Eva eRettinger, et al. SMAC Mimetic BV6 Enables Sensitization of Resistant Tumor Cells but Also Affects Cytokine-induced Killer (CIK) Cells: A Potential Challenge for Combination Therapy. Frontiers Media S.A., 2014.

MLA (9th ed.) Citation

Eva eRettinger, et al. SMAC Mimetic BV6 Enables Sensitization of Resistant Tumor Cells but Also Affects Cytokine-induced Killer (CIK) Cells: A Potential Challenge for Combination Therapy. Frontiers Media S.A., 2014.